# DiaPharma Group Inc – FDA Inspection, Apr 29, 2022

Source: https://www.keypedia.com/records/fda_inspections/diapharma-group-inc/b493f4de-ab73-489d-acc0-f6ce6e28fda6
Source feed: FDA_Inspections

> FDA inspection 1171225 of DiaPharma Group Inc, April 29, 2022. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 820. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1171225
- Company Name: DiaPharma Group Inc
- Inspection Date: 2022-04-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Compliance: Devices
- Product Type: Devices
- Center: Medical Devices & Rad Health
- Office Name: Center for Devices and Radiological Health
- Citation Count: 1

## Related Documents

- FDA Inspection 1306606 - 2026-02-25
- FDA Inspection 940414 - 2015-08-31
- FDA Inspection 749173 - 2011-10-11
- [FDA Inspection 712065 - 2011-03-08](https://www.keypedia.com/records/fda_inspections/diapharma-group-inc/79edb58b-f83d-409f-90da-800a7af2be94)

Company: https://www.keypedia.com/companies/diapharma-group-inc/1778c90b-7a40-4a54-b058-a6f4ec274e7a

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7